Scleroderma Flashcards

1
Q

Clinical features of scleroderma

A

.best evaluated using a combination of endoscopy and barium x-ray study.
scleroderma = endoscopic findings relate to a hypotensive lower esophageal sphincter.
Symptoms include heartburn, dysphagia due to stricture or esophageal dysmotility, and pain due to diffuse spasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Clinical features of sjogren’s syndrome

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Distinctive autoantibodies that are associated with SSc and sjogren’s syndrome

A
.Diffuse = antibodies against topoisomerase 1 (scl-70)
Limited = antibodies against centromere
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Histopathology distinguishing SSc and Sjogren’s from other connective diseases

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Types of scleroderma and distributions

A

Diffuse = all over the body
Limited = head, hands, legs below the thighs
Sine Sclerosis = internal organs, no hard skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Skin findings in scleroderma

A
  • early = swelling of fingers and hands (puffy/edematous phase) with erythema and pruritis
  • later = shiny, tight and thick with pigment changes, sclerodactyly and digital ulcers/pitting at the fingertips
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Characteristics of sine sclerosis

A
  • 5% of people with scleroderma have sine sclerosis
  • Raynaud’s, GI abnormalities, autoantibodies and telengiectasia
  • diagnosis often delayed
  • prognosis is the same as limited disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Characteristics of limited systemic sclerosis

A

CREST

  • calcinosis - can appear in fingers, sodium thiosulfate can help them come to the surface and be removed, late manifestation, never occurs in diffuse disease
  • raynaud’s phenomenon - can be the first symptom by months or years
  • esophageal dysmotility
  • sclerodactyly
  • telengiectasia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

x-ray findings in fingers with calcinosis in Ssc

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pattern of Raynaud’s phenomenon in SSc

A
  • cold induced vasospasm with blanching/pallor, cyanosis, reactive hyperremia
  • present in 95% of patients with SSc
  • vasospasm and structural changes in the small blood vessels (vasculopathy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the structural changes seen in vasculopathy associates with SSc

A
  • reduction in finger pad, tapering of fingers
  • fingertip ischemia/necrosis
  • necrosis over PIP/MCP/Ulnar styloid/Elbow
  • Abnormal nail fold capillaries
  • blood vessel wall thickening = actual lumen is blocked
    Can proceed to gangrene if blood flow is not restored
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

most specific finding in making a diagnosis of CTD in patient with Raynaud’s

A

dilated nailfold capillaries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Variation in nailfold capillary pathology in SSc

A
  1. Dilated
  2. Drop out and hemorrhage
  3. Significant drop out of blood vessels = bad
    This is a helpful finding in a patient in whom you suspect raynaud’s secondary to a CTD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Appearance of esophageal dysmotility on barium swallow

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Xray finding in SSc sclerodactyly

A

Resorption of the tufts of the terminal phalanges: acro-osteolysis
Also see joint deformity due to the skin tightening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Appearance of SSc telengiectasia

A

Appears on fingers, hands and face

  • less than 1mm but can grow
  • in GI tract, can cause significant blood loss
17
Q

Differences between diffuse vs limited SSc

A

Diffuse: skin changes more on front than back of torso; early organ involvement; renal crisis; pulmonary fibbrosis; antibodies against topoisomerase 1 (Scl-70)

Limited: CREST, Calcinosis, pulmonary hypertension (10-15%), antibodies against centromere

18
Q

Pathophysiology of scleroderma includes:

A
  • vasculopathy
  • activation of cellular immunity
  • activation of humoral immunity
  • fibrosis
    DOES NOT include vasculitis